A critical advance in cancer investigation is occurring with the use of mini-antibodies to reactivate mutated p53. This vital malignant suppressor protein is frequently disabled in several kinds of cancer, leading https://www.zenhealths.com/p53-reactivation-nanobody-cancer-research